Abramova, R., Brown, M., Thomas, C., Salerno, D., Assal, A., & Campbell, P. (2023). Evaluation of a Protocol for Reducing Venous Thromboembolism in Hematopoietic Stem Cell Transplant Recipients. Journal of Pharmacy Practice, 37(4), 807–809. https://doi.org/10.1177/08971900231193531

Buch, M. H., Bhatt, D. L., Charles-Schoeman, C., Giles, J. T., Mikuls, T., Koch, G. G., Ytterberg, S., Nagy, E., Jo, H., Kwok, K., Connell, C. A., Masri, K. R., & Yndestad, A. (2024). Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study. RMD Open, 10(2), e003912. https://doi.org/10.1136/rmdopen-2023-003912

Guzman-Pruneda, F. A., Garcia, A., Crum, R. W., Chen, T., Krikhely, A., & Bessler, M. (2024). Extended Post Discharge Prophylaxis for Venous Thromboembolism Prevention After Bariatric Surgery. Obesity Surgery, 34(4), 1217–1223. https://doi.org/10.1007/s11695-024-07100-z

Bejjani, A., Khairani, C. D., Assi, A., Piazza, G., Sadeghipour, P., Talasaz, A. H., Fanikos, J., Connors, J. M., Siegal, D. M., Barnes, G. D., Martin, K. A., Angiolillo, D. J., Kleindorfer, D., Monreal, M., Jimenez, D., Middeldorp, S., Elkind, M. S. V., Ruff, C. T., Goldhaber, S. Z., … Bikdeli, B. (2024). When Direct Oral Anticoagulants Should Not Be Standard Treatment. Journal of the American College of Cardiology, 83(3), 444–465. https://doi.org/10.1016/j.jacc.2023.10.038

Ujueta, F. (2023). Low Dietary Manganese and the Incidence of Venous Thromboembolism: Evidence for Minerals and Vitamins and the Other Comorbidities Linked to Venous Thromboembolism. Thrombosis and Haemostasis, 124(06), 555–556. CLOCKSS. https://doi.org/10.1055/a-2225-5513

Katiyar, P., Chase, H., Lenke, L. G., Weidenbaum, M., & Sardar, Z. M. (2023). Using Machine Learning (ML) Models to Predict Risk of Venous Thromboembolism (VTE) Following Spine Surgery. Clinical Spine Surgery: A Spine Publication, 36(10), E453–E456. https://doi.org/10.1097/bsd.0000000000001498

Snyder, D. J., Zilinyi, R. S., Cohen, D. J., Parikh, S. A., & Sethi, S. S. (2023). Patient‐Reported Outcomes in Venous Thromboembolism: A Systematic Review of the Literature, Current Challenges, and Ways Forward. Journal of the American Heart Association, 12(23). https://doi.org/10.1161/jaha.123.032146

Akpan, I. J., & Hunt, B. J. (2023). How I approach the prevention and treatment of thrombotic complications in hospitalized patients. Blood, 142(9), 769–776. https://doi.org/10.1182/blood.2021014835

Scanlon, L. R., Khaksari, B., Goel, S., Nevadunsky, N. S., Wright, J. D., & Gressel, G. M. (2023). Direct oral anticoagulant (DOACs) prescribing practices of members of the Society of Gynecologic Oncology and American Society of Clinical Oncology. Gynecologic Oncology, 173, 68–73. https://doi.org/10.1016/j.ygyno.2023.04.012

Goel, R., Plimier, C., Lee, C., Tobian, A. A. R., Josephson, C. D., Hod, E. A., & Roubinian, N. H. (2023). Blood donor, component, and recipient‐specific factors associated with venous thromboembolism in transfused hospitalized adult patients: Data from the recipient epidemiology and donor evaluation Study‐III (REDS‐III). Transfusion, 63(5), 925–932. Portico. https://doi.org/10.1111/trf.17292

Suzuki, Y., Chen, L., Hou, J. Y., St. Clair, C. M., Khoury-Collado, F., de Meritens, A. B., Matsuo, K., Melamed, A., Hershman, D. L., & Wright, J. D. (2023). Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia. Obstetrics & Gynecology, 141(5), 979–987. https://doi.org/10.1097/aog.0000000000005124

Zuckerman, S. L., Leung, E., Streiff, M. B., Kerolus, M., Buchanan, I. A., Ha, A., Bonfield, C. M., Buchholz, A. L., Buchowski, J. M., Burch, S., Devin, C. J., Dimar, J. R., Gum, J. L., Good, C., Kim, H. J., Kim, J. S., Lombardi, J. M., Mandigo, C. E., Bydon, M., … Lehman, R. A. (2022). Management of Anticoagulation/Antiplatelet Medication and Venous Thromboembolism Prophylaxis in Elective Spine Surgery: Concise Clinical Recommendations Based on a modified Delphi Process. Spine. https://doi.org/10.1097/brs.0000000000004540

O’Shaugnessy, F., Govindappagari, S., Huang, Y., Syeda, S. K., D’Alton, M. E., Wright, J. D., & Friedman, A. M. (2021). Postthrombotic Syndrome and Chronic Pulmonary Embolism after Obstetric Venous Thromboembolism. American Journal of Perinatology, 40(01), 022–024. CLOCKSS. https://doi.org/10.1055/s-0041-1739471

Chakraborty, R., Rybicki, L., Wei, W., Valent, J., Faiman, B. M., Samaras, C. J., Anwer, F., & Khorana, A. A. (2022). Abnormal metaphase cytogenetics predicts venous thromboembolism in myeloma: derivation and validation of the PRISM score. Blood, 140(23), 2443–2450. https://doi.org/10.1182/blood.2022015727

O’Shaugnessy, F., Syeda, S. K., Huang, Y., D’Alton, M. E., Wen, T., Wright, J. D., & Friedman, A. M. (2021). Receipt of anticoagulation after venous thromboembolism diagnoses during delivery hospitalizations. The Journal of Maternal-Fetal & Neonatal Medicine, 35(25), 6353–6355. https://doi.org/10.1080/14767058.2021.1912000

Schuster, M., Ananth, C. V., Gomez, D., Huang, Y., Gyamfi-Bannerman, C., Wright, J. D., D’Alton, M. E., & Friedman, A. M. (2021). 17-alpha hydroxyprogesterone caproate and risk for venous thromboembolism during pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine, 35(25), 6336–6337. https://doi.org/10.1080/14767058.2021.1911997

Martínez-Alés, G., Domingo-Relloso, A., Quintana-Díaz, M., Fernández-Capitán, C., & Hernán, M. A. (2022). Thromboprophylaxis with standard-dose vs. flexible-dose heparin for hospitalized COVID-19 patients: a target trial emulation. Journal of Clinical Epidemiology, 151, 96–103. https://doi.org/10.1016/j.jclinepi.2022.08.006

Faye, A. S., Lee, K. E., Dodson, J., Chodosh, J., Hudesman, D., Remzi, F., Wright, J. D., Friedman, A. M., Shaukat, A., & Wen, T. (2022). Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis. Alimentary Pharmacology & Therapeutics, 56(7), 1157–1167. Portico. https://doi.org/10.1111/apt.17162

Huang, H., Bernstein, J. L., & Otterburn, D. M. (2022). Prolonged Venous Thromboembolism Prophylaxis May Not Be Necessary for DIEP Flap Breast Reconstruction: A Tertiary Center’s 10-Year Experience. Journal of Reconstructive Microsurgery, 38(08), 647–653. CLOCKSS. https://doi.org/10.1055/s-0042-1742734

Cuker, A., Tseng, E. K., Nieuwlaat, R., Angchaisuksiri, P., Blair, C., Dane, K., DeSancho, M. T., Diuguid, D., Griffin, D. O., Kahn, S. R., Klok, F. A., Lee, A. I., Neumann, I., Pai, A., Righini, M., Sanfilippo, K. M., Siegal, D. M., Skara, M., Terrell, D. R., … Schünemann, H. J. (2022). American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients. Blood Advances, 6(17), 4915–4923. https://doi.org/10.1182/bloodadvances.2022007561

Cuker, A., Tseng, E. K., Schünemann, H. J., Angchaisuksiri, P., Blair, C., Dane, K., DeSancho, M. T., Diuguid, D., Griffin, D. O., Kahn, S. R., Klok, F. A., Lee, A. I., Neumann, I., Pai, A., Righini, M., Sanfilippo, K. M., Siegal, D. M., Skara, M., Terrell, D. R., … Nieuwlaat, R. (2022). American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients. Blood Advances, 6(17), 4975–4982. https://doi.org/10.1182/bloodadvances.2022007940

Lerner, R. K., Lotan, D., Oren, D., Itelman, E., Neeman, Y., Dekel, S., Heller, E., Abu-Much, A., Shilo, N., Gilead, R., Hubara, E., Mouallem, M., Haviv, Y., Kogan, A., Mayan, H., & Pessach, I. M. (2022). Prevalence and clinical implication of thrombocytopenia and heparin-induced thrombocytopenia in patients who are critically ill with COVID-19. Clinical Medicine, 22(5), 403–408. https://doi.org/10.7861/clinmed.2022-0054

Langouo Fontsa, M., Aiello, M. M., Migliori, E., Scartozzi, M., Lambertini, M., Willard-Gallo, K., & Solinas, C. (2022). Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research. Targeted Oncology, 17(5), 497–505. https://doi.org/10.1007/s11523-022-00908-8

Kainuma, A., Ning, Y., Kurlansky, P. A., Wang, A. S., Latif, F., Farr, M. A., Sayer, G. T., Uriel, N., Takayama, H., Naka, Y., & Takeda, K. (2022). Deep vein thrombosis and pulmonary embolism after heart transplantation. Clinical Transplantation, 36(7). Portico. https://doi.org/10.1111/ctr.14705

Bikdeli, B., Zahedi Tajrishi, F., Sadeghipour, P., Talasaz, A. H., Fanikos, J., Lippi, G., Siegal, D. M., Eikelboom, J. W., Monreal, M., Jimenez, D., Connors, J. M., Ageno, W., Barnes, G. D., Piazza, G., Angiolillo, D. J., Parikh, S. A., Kirtane, A. J., Lopes, R. D., Bhatt, D. L., … Lip, G. Y. H. (2022). Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants. JAMA Cardiology, 7(7), 747. https://doi.org/10.1001/jamacardio.2022.1292

Weber, M., Chao, M., Kaur, S., Tran, B., & Dizdarevic, A. (2022). A Look Forward and a Look Back. Clinics in Sports Medicine, 41(2), 345–355. https://doi.org/10.1016/j.csm.2021.11.007

Kishore, S. A., Bajwa, R., Van Doren, L., Wilkins, C., & O’Sullivan, G. J. (2022). Endovascular Management of Venous Thromboembolic Disease in the Oncologic Patient Population. Current Oncology Reports, 24(3), 351–362. https://doi.org/10.1007/s11912-022-01191-6